ARTICLE | Clinical News
FDA approves Adamis' Symjepi epinephrine pre-filled syringe
June 30, 2017 7:00 PM UTC
Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) said FDA approved an NDA for Symjepi epinephrine for the emergency treatment of allergic reactions including anaphylaxis. Symjepi is a pre-filled syringe containing a single dose of 0.3 mg epinephrine. Adamis plans to launch the product this half...
BCIQ Company Profiles